News in the Life Sciences Industry

LONDON, Feb. 28, 2020 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood onset neurogenetic disorders with limited or no treatment options, today announced that its management will present a corporate overview at the Cowen... Read more ››

LONDON, Feb. 28, 2020 /PRNewswire/ -- Cello Health has been recognised as number 71 on the annual Sunday Times Best Companies to Work For list, which showcases the best of employee engagement across the private sector.

HERTFORDSHIRE, England and PITTSBURGH, Feb. 27, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced its financial results for the fourth quarter and the year ended December 31, 2019 and provided 2020 guidance.

STAINES-UPON-THAMES, United Kingdom, Feb. 27, 2020 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company,... Read more ››

HERTFORDSHIRE, England and PITTSBURGH and NEW YORK, Feb. 27, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced the remaining appointees to the inaugural 13-member Board of Directors for Viatris, the new company that will result from the combination of Mylan... Read more ››

HERTFORDSHIRE, England and PITTSBURGH and NEW YORK, Feb. 27, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Pfizer (NYSE: PFE) today announced that Sanjeev Narula, current chief financial officer (CFO) of Upjohn, a division of Pfizer, has been named incoming CFO of Viatris, the new company... Read more ››

OSLO, Feb. 27, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) publiserer i dag sine resultater for fjerde kvartal 2019. Selskapets ledelse vil gi en presentasjon av resultatene klokken 08:30 på Thon Hotel Vika Atrium i Oslo. Se ytterligere informasjon nedenfor.

OSLO, Norway, Feb. 27, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces its results for the fourth quarter and full year 2019. A presentation by the company's senior management team will take place today in Oslo at 08:30 CET, see details below.

LONDON, Feb. 27, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, and Glenmark Specialty S.A., a Swiss subsidiary of Glenmark Pharmaceuticals, a global innovative pharmaceutical company, today announce the signing of an exclusive... Read more ››